Walbert Keli
Spruce Biosciences, Inc. · Director
Walbert Keli is listed in filings as Director at Spruce Biosciences, Inc.. This profile follows SEC Form 4 activity through May 26, 2026, including 8 public disclosures. Recent filings connect the profile to Spruce Biosciences, Inc. (SPRB) and Apellis Pharmaceuticals, Inc. (APLS). The current snapshot covers public activity from Dec 15, 2025 to May 26, 2026. Reported amounts are shown as $89.6K to $368.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.
History Trades
| Company | Value | Action | Price | Current Price |
|---|---|---|---|---|
| Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available. | ||||